Ruiqi Zhao
Shenzhen, 518033, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Deep Learning-Based Virtual Screening Identifies Potential Small-Molecule Inhibitors of ASK1: Natural Product Lead Discovery for MASH.
Journal: International journal of molecular sciences
Published: June 10, 2026
Multi-Omics Integrative Analysis Identifies the NK Cell-STAT3 Axis as a Shared Immunogenetic Hub Underlying the Comorbidity of Primary Sclerosing Cholangitis and Ulcerative Colitis.
Journal: Life (Basel, Switzerland)
Published: April 02, 2026
Hypophosphatemia as a Potential Class Effect of Histone Deacetylase Inhibitors: Evidence from Disproportionality Analysis and Mendelian Randomization Analysis of Drug Targets.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 31, 2026
Computational Discovery of Dual-Target LDHA/BRD4 Inhibitors Targeting the Lactate-Kla-B7-H3 Immunosuppressive Axis Through AI-Driven Virtual Screening.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 27, 2026
Bioinformatics Profiling of a Paeoniflorin-Associated "Macrophage-Lactylation" Axis in Hepatocellular Carcinoma: An LDHA-Based Prognostic Model and Structural Computational Evidence.
Journal: International journal of molecular sciences
Published: February 05, 2026
NAFLD and Hypothyroidism: Deciphering Pivotal Genetic Variants, Cellular Expression Landscapes, and Spatial Architectures.
Journal: International journal of molecular sciences
Published: January 13, 2026
Risk assessment of drug-associated miscarriage using XGBoost and SHAP explainability: a real-world pharmacovigilance analysis based on the FAERS database.
Journal: Frontiers in pharmacology
Published: October 01, 2025
Assessing the risk of acute kidney injury associated with a four-drug regimen for heart failure: a ten-year real-world pharmacovigilance analysis based on FAERS events.
Journal: Expert opinion on drug safety
Published: February 13, 2025
Global trends in testicular and prostate cancer among adolescents and young adult males aged 15-49 years, 1990-2021: insights from the GBD study.
Journal: Scientific reports
Published: December 05, 2024
Peripheral blood cell counts as predictors of immune-related adverse events in cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis.
Journal: Frontiers in immunology
Published: November 14, 2024
Last Updated: 09/26/2026